Vaccine Adverse Event Reporting System (VAERS)

Nov 14, 2014

130 likes | 466 Views

Vaccine Adverse Event Reporting System (VAERS). Online Reporting January 23, 2003. Submission of Supporting Documents for VAERS Reports. Examples: medical records or other clinical documentation

Share Presentation

Embed Code

Link

fax
report number
clinical documentation
supporting documents
fax cover sheet
cut paste electronic information

kaitlin-hays

Download Presentation

Vaccine Adverse Event Reporting System (VAERS)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Vaccine Adverse Event Reporting System(VAERS) Online Reporting January 23, 2003

Submission of Supporting Documents for VAERS Reports • Examples: medical records or other clinical documentation • Submit initial report electronically, then fax or mail supporting documents noting VAERS E-Report number, PVN or the unique vaccination number in the upper right hand corner of each page or on a fax cover sheet. • Cut & paste electronic information into Box 7, 12, 17, 18, and/or 19

New Adverse Event Reporting Policy

New Adverse Event Reporting Policy. Effective September 1, 2007. Local adverse event reporting. Local adverse events are those experienced by subjects enrolled by the investigator(s) at this institution or in the local community area

636 views • 33 slides

Adverse Event Reporting: Getting started

Adverse Event Reporting: Getting started. Lynn Bahta, R.N., B.S.N Minnesota Department of Health August 2008. Early promptings. Growing interest in vaccine safety issues in Minnesota Very active and articulate anti-vaccine groups Safety questions raised about new vaccines

688 views • 30 slides

Serious Adverse Event and Reaction reporting

Serious Adverse Event and Reaction reporting . 25 March 2009 Emyr Harries. Aims and outcomes. Provide definitions of Serious Adverse Events and Reactions (SAEARs) What are the criteria for reporting SAEARs? When and how should the information be provided to the HTA?

285 views • 13 slides

DHS Adverse Event Reporting Requirements

DHS Adverse Event Reporting Requirements . With Associated Revisions to the UCLA Event Reporting System Presented by the Quality Resource Department June 6, 2007. Senate Bill 1301.

527 views • 31 slides

FDA/CBER Role in Smallpox Vaccine Safety

FDA/CBER Role in Smallpox Vaccine Safety . Bob Ball, MD, MPH, ScM Chief, Vaccine Safety Branch Office of Biostatistics and Epidemiology CBER, FDA January 23, 2003. FDA/CBER Role in Smallpox Vaccine Safety. Office of Biostatistics and Epidemiology Vaccine Safety Branch VAERS Follow-up

281 views • 6 slides

VA Adverse Drug Event Reporting System (VA ADERS)

VA Adverse Drug Event Reporting System (VA ADERS). Thomas Emmendorfer, PharmD VA PBM Services. VAMedSAFE Mission. Preventable adverse drug events Identify Track Address Improve the safety of: Drug prescribing practices Medication administration . VA ADERS Time Line.

951 views • 23 slides

Improving Patient Safety Through Adverse Event Reporting

Improving Patient Safety Through Adverse Event Reporting. Kathy Schmitt, MPA Research Analysis and Data Section Manager Office of Community Health Systems Washington State Department of Health. Improving Patient Safety Through Adverse Event Reporting.

342 views • 8 slides

Smallpox Vaccine Safety and Reporting Adverse Events

Smallpox Vaccine Safety and Reporting Adverse Events. Department of Health and Human Services Centers for Disease Control and Prevention February 2003. Smallpox Vaccine Safety and Reporting Adverse Events . Learning Objectives:

391 views • 17 slides

Thanks for Asking! A Family-Initiated Adverse Event Reporting System

Thanks for Asking! A Family-Initiated Adverse Event Reporting System. Mark Ansermino Donna Tack Jeremy Daniels. Department of Anesthesiology & Partners in Care BC Children’s Hospital, Vancouver, British Columbia, Canada . Our Team.

511 views • 36 slides

Serious Adverse Event Reporting

Serious Adverse Event Reporting. Start-up Meeting March 25, 2010 Kingston, ON. Procedures. Using Pfizer Products MUST follow Pfizer SAE reporting policies. SAEs Defined. Any untoward medical occurrence that at any dose results in: Death Is life-threatening

901 views • 16 slides

Adverse Event Reporting

Adverse Event Reporting. Reporting Adverse Events. Adverse Events (AEs) are “. . . any untoward medical occurrence in a subject that was not previously identified which does not necessarily have a causal relationship to the study drug…”

915 views • 22 slides

Adverse Drug Event Reporting

Adverse Drug Event Reporting. Pharmacy Department Dale Tucker, RPh, BCPS Detroit Medical Center Last Updated July 2005 by Julie Berman (DRH), Albert Bajjoka (HVSH), May Saba (CHM), Kim Tsilimingras (SGH), & Dale Tucker (HUH). Goals and Objectives.

553 views • 30 slides

Session 4 Adverse Event Reporting

Session 4 Adverse Event Reporting. Deborah A. Zarin, M.D. Pilot Quality Control Project Recommendation to Secretary – Narrative Summaries. Expanded Clinical Trial Registry. REGISTRY. New Administration Transition Phase. Public Meeting. 9/27/07. 12/26/07. 9/27/08. 3/27/09. 9/27/10.

348 views • 15 slides

Adverse Event reporting in clinical trials

Adverse Event reporting in clinical trials. Overview. Covering. Definitions Terminology Reporting requirements Legislation Researchers responsibilities Practicalities Examples Question and answers. What are Adverse Events? (AE). Definition -

4.06k views • 37 slides

Status of Adverse Event Public Reporting

Status of Adverse Event Public Reporting. Ben Steffen Presented to the Maryland Health Quality and Cost Council September 19, 2014. Background. Maryland’s approach to monitoring comprehensive adverse events monitoring OHCQ MHCC, HSCRC Maryland Patient Safety Center

193 views • 9 slides

Smallpox Vaccine Safety and Reporting Adverse Events

Smallpox Vaccine Safety and Reporting Adverse Events. Department of Health and Human Services Centers for Disease Control and Prevention December 2002. Smallpox Vaccine Safety and Reporting Adverse Events. Learning Objectives:

440 views • 24 slides

Smallpox Outbreak and Vaccine Adverse Event Laboratory Support

Smallpox Outbreak and Vaccine Adverse Event Laboratory Support. Rash Evaluation Flow. Poxviruses. Two Subfamilies: Chordopoxvirinae (vertebrate poxviruses) Orthopoxvirus (variola, vaccinia, cowpox, monkeypox, raccoonpox, camelpox, skunkpox, volepox, ectromelia, taterapox) Others

483 views • 35 slides

Influenza Vaccine Safety in Children: Data from VAERS 1991-2001

Influenza Vaccine Safety in Children: Data from VAERS 1991-2001. John Iskander MD MPH Gina Mootrey DO MPH Penina Haber MPH Roseanne English-Bullard BS Karen Broder MD FAAP. Background on VAERS. National passive surveillance system for adverse events occurring after vaccination

269 views • 19 slides

Adverse Event Reporting: Trials and Tribulations

Adverse Event Reporting: Trials and Tribulations. Joanne R. Less, Ph.D. Director, IDE and HDE Programs ODE, CDRH, FDA Second Annual Medical Research Summit Grand Hyatt Hotel March 26, 2002. Adverse Event Reporting: Trials and Tribulations. I. Definitions and Reporting Requirements

313 views • 14 slides

Expedited Adverse Event Reporting Requirements

Expedited Adverse Event Reporting Requirements. Protocol References. Other References and Resources. Manual for Expedited Reporting of Adverse Events to DAIDS (Version 2.0) DAIDS Table for Grading the Severity of Adult and Pediatric Adverse Events, Corrected Version 2.1 , dated July 2017

367 views • 34 slides

GCPs V Adverse Event Monitoring and Reporting

GCPs V Adverse Event Monitoring and Reporting. FDA Inspection. Common Deficiencies Inadequate consent 51% Protocol Non-adherence 31% Records Inadequate/Inaccurate 26% Drug Accountability Inadequate 20% IRB deficiencies 11% Investigator Failure to report Adverse Events.

309 views • 27 slides

Data Mining in VAERS to Enhance Vaccine Safety Monitoring at the FDA

Data Mining in VAERS to Enhance Vaccine Safety Monitoring at the FDA. Robert Ball, MD, MPH, ScM Dale Burwen MD, MPH M. Miles Braun, MD, MPH Division of Epidemiology Office of Biostatistics and Epidemiology DIMACS, October 18, 2002. What is the Vaccine Adverse Event Reporting System (VAERS)?.

281 views • 26 slides

More Related